Rapid efficient synthesis and characterization of silver, gold, and bimetallic nanoparticles from the medicinal plant Plumbago zeylanica and their application in biofilm control

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2635-2653

  Salunke, Gayatri R ^a   Ghosh, Sougata ^a   Santosh Kumar, R J ^b   Khade, Samiksha ^a   Vashisth, Priya ^c   Kale, Trupti ^d   Chopade, Snehal ^a   Pruthi, Vikas ^c   Kundu, Gopal ^d   Bellare, Jayesh R ^e   Chopade, Balu A ^a  

^a UNIVERSITY OF PUNE   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

^d NATIONAL CENTRE FOR CELL SCIENCE   (India)

^e INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

AgAuNPs; AgNPs; AuNPs; Biofilm inhibition and disruption; GC TOF MS; P. zeylanica

Indexed keywords

CARBOXYLIC ACID; CHLORINE DERIVATIVE; CITRIC ACID; FLAVONOID; FRUCTOSE; GLUCOSE; GOLD NANOPARTICLE; GOLD SILVER NANOPARTICLE; GOLD TRICHLORIDE ACID; NANOPARTICLE; PHENOL; PLUMBAGIN; PLUMBAGO ZEYLANICA EXTRACT; SILVER NANOPARTICLE; SILVER NITRATE; STARCH; SUCROSE; SUGAR; UNCLASSIFIED DRUG; WATER; ALLOY; ANTIINFECTIVE AGENT; METAL NANOPARTICLE; PLANT EXTRACT;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOFILM; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MASS FRAGMENTOGRAPHY; NANOANALYSIS; NANOFABRICATION; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; QUANTITATIVE ANALYSIS; REDUCTION; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; TIME OF FLIGHT MASS SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; APOPTOSIS; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MEDICINAL PLANT; PLUMBAGINACEAE; SYNTHESIS; ULTRASTRUCTURE;

ALLOYS; ANTI-BACTERIAL AGENTS; APOPTOSIS; BIOFILMS; METAL NANOPARTICLES; PLANT EXTRACTS; PLANT ROOTS; PLANTS, MEDICINAL; PLUMBAGINACEAE;

EID: 84901501597     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S59834     Document Type: Article

References (74)

1. Tran QH, Nguyen VQ, Le A. Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Adv Nat Sci Nanosci Nanotechnol. 2013;4(3):033001.
2. Elavazhagan T, Arunachalam K. Memecylon edule leaf extract mediated green synthesis of silver and gold nanoparticles. Int J Nanomedicine. 2011;6:1265-1278.
3. Ghosh S, Patil S, Ahire M, et al. Synthesis of gold nanoanisotrops using Dioscorea bulbifera tuber extract. J Nanomater. 2011;2011:354793.
4. He S, Zhirui G, Zhang Y, Zhang S, Wang J, Gu N. Biosynthesis of gold nanoparticles using the bacteria Rhodopseudomonas capsulata. Mater Lett. 2007;61(18):3984-3987.
5. Mourato A, Gadanho M, Lino AR, Tenreiro R. Biosynthesis of crystalline silver and gold nanoparticles by extremophilic yeasts. Bioinorg Chem Appl. 2011;2011:546074.
6. Mukherjee P, Ahmad A, Mandal D, et al. Fungus-mediated synthesis of silver nanoparticles and their immobilization in the mycelial matrix: a novel biological approach to nanoparticle synthesis. Nano Lett. 2001;1(10):515-519.
7. Govindaraju K, Kiruthuga V, Kumar VG, Singaravelu G. Extracellular synthesis of silver nanoparticles by a marine alga, Sargassum wightii Grevilli and their antibacterial effects. J Nanosci Nanotechnol. 2009;9(9):5497-5501.
8. Chopade NB, Ghosh S, More P, et al. Biogenic copper nanoparticles as novel antidiabetic and antioxidant in nanomedicine. Poster presented at: Second International Translational Nanomedicine Conference; July 26-28, 2013; Boston, MA.
9. Khan M, Khan M, Adil SF, et al. Green synthesis of silver nanoparticles mediated by Pulicaria glutinosa extract. Int J Nanomedicine. 2013:81507-81516.
10. Woo KJ, Hye CK, Ki WK, Sook S, So HK, Yong HP. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Env Microbiol. 2008;74(7):2171-2178.
11. He Y, Du Z, Lv H, et al. Green synthesis of silver nanoparticles by Chrysanthemum morifolium Ramat. Extract and their application in clinical ultrasound gel. Int J Nanomedicine. 2013;8:1809-1815.
12. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76-83.
13. Shakibaie MR, Dhakephalkar P, Kapadnis BP, Chopade BA. Removal of silver from photographic wastewater effluent using Acinetobacter baumannii BL54. Can J Microbiol. 1999;45(12):995-1000.
14. Waters AE, Contente-Cuomo T, Buchhagen J, et al. Multidrug-resistant Staphylococcus aureus in US meat and poultry. Clin Infect Dis. 2011;52(10):1227-1230.
15. Dhakephalkar PK, Chopade BA. High levels of multiple metal resistance and its correlation to antibiotic resistance in environmental isolates of Acinetobacter. Biometals. 1994;7(1):67-74.
16. Chopra I. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother. 2007;59(4):587-590.
17. Singh R, Wagh P, Wadhwani S, et al. Synthesis, optimization, and characterization of silver nanoparticles from Acinetobacter calcoaceticus and their enhanced antibacterial activity when combined with antibiotics. Int J Nanomedicine. 2013;8:4277-4290.
18. Shebdadkar U, Singh R, Wadhawani S, Chopade BA. Microbial synthesis of gold nanoparticles: current status and future prospects. Adv Colloid Interface Sci. Epub 2014 Jan 2.
19. Glomm WR. Functionalized gold nanoparticles for applications in bionanotechnology. J Dispers Sci Technol. 2005;26(3):389-414.
20. Song JY, Kim BS. Biological synthesis of bimetallic Au/Ag nanoparticles using persimmon (Diopyros kaki) leaf extract. Korean J Chem Eng. 2008;25(4):808-811.
21. Shankar SS, Rai A, Ahmad A, Sastry M. Rapid synthesis of Au, Ag, and bimetallic Au core-Ag shell nanoparticles using neem (Azadirachta indica) leaf broth. J Colloid Interface Sci. 2004;275(2):496-502.
22. Patwardhan RB, Dhakephalkar P, Chopade BA. Medicinal importance of chitraka plant: a review. Shrushti Health Bull. 2005;4:4-5.
23. Ahmad I, Beg AZ. Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. J Ethnopharmacol. 2001;74(2):113-123.
24. van der Vijver LM. Distribution of plumbagin in the mplumbaginaceae. Phytochemistry. 1972;11(11):3247-3248.
25. de Paiva SR, Figueiredo M, Aragão TV, Kaplan MA. Antimicrobial activity in vitro of plumbagin isolated from Plumbago species. Mem Inst Oswaldo Cruz. 2003;98(7):959-961.
26. Shakibaie MR, Dhakephalkar PK, Kapadnis BP, Salayaghe G, Chopade BA. Plasmid mediated silver and antibiotic resistance in Acinetobacter baumannii BL54. Iran J Med Sci. 1998;23(12):30-36.
27. Deshpande LM, Chopade BA. Plasmid mediated silver resistance in Acinetobacter baumannii BL54. Biometals. 1994;7(1):49-56.
28. Dhale DA, Markandeya SK. Antimicrobial and phytochemical screening of Plumbago zeylanica Linn. (Plumbaginaceae) leaf. J Exp Sci. 2011;2(3):4-6.
29. Asharani PV, Mun GLK, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3(2):279-290.
30. Egorova EM, Revina AA. Synthesis of metallic nanoparticles in reverse micelles in the presence of quercetin. Colloids Surf A Physicochem Eng Asp. 2000;168(1):87-96.
31. Panigrahi S, Kundu S, Ghosh SK, Nath S, Pal T. General method of synthesis for metal nanoparticles. J Nanopart Res. 2004;6(4):411-414.
32. Zhao X, Shi Y, Wang T, Cai Y, Jiang G. Preparation of silica-magnetite nanoparticle mixed hemimicelle sorbents for extraction of several typical phenolic compounds from environmental water samples. J Chromatogr A. 2008;1188(2):140-147.
33. Chothani DL, Patel MB, Mishra SH. HPTLC fingerprint profile and isolation of marker compound of Ruellia tuberosa. Chromatogr Res Int. 2012;2012:180103.
34. Skalska-Kamińska A, Matysik G, Wójciak-Kosior M, Donica H, Sowa I. Thin-layer chromatography of sugars in plant material. Curr Issue Pharm Med Sci. 2009;22(4):17-24.
35. Parveen I, Moorby JM, Fraser MD, Allison GG, Kopka J. Application of GCMS-TOF metabolite profiling techniques to the analysis of heathland plant diets of sheep. J Agric Food Chem. 2007;55(4):1129-1138.
36. Dubois M, Gilles DA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for the determination of sugars and related substances. Anal Chem. 1956;28(3):350-356.
37. Ghosh S, Patil S, Ahire M, et al. Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents. Int J Nanomedicine. 2012;7:483-496.
38. Israni SA, Kapadia NS, Lahiri SK, Yadav G, Shah MB. An UV-visible spectrophotometric method for the estimation of plumbagin. Int J Chem Tech Res. 2010;2(2):856-859.
39. Augustine R, Rajarathinam R. Synthesis and characterization of silver nanoparticles and its immobilization on alginate coated sutures for the prevention of surgical wound infections and the in vitro release studies. Int J Nano Dimens. 2012;2(3):205-212.
40. Deshpande LM, Kapadnis, Chopade BA. Metal resistance in Acinetobacter and its relation to β-lactamase production. Biometals. 1993;6(1):55-59.
41. Sahu PK, Iyer PS, Oak A, Pardeshi K, Chopade BA. Characterization of eDNA from the clinical strain Acinetobacter baumannii AIIMS 7 and its role in biofilm formation. Scientific World Journal. 2012;2012:973436.
42. Gaidhani SV, Singh R, Singh D, et al. Biofilm disruption activity of silver nanoparticles synthesized by Acinetobacter calcoaceticus PUCM 1005. Mater Lett. 2013;108:324-327.
43. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175-179.
44. Kishore N, Mishra BB, Tiwari V, Tripathi V. An account of phytochemicals from Plumbago zeylanica (Family: Plumbaginaceae): a natural gift to human being. Chron Young Sci. 2012;3(3):178-198.
45. Swarnavalli GCJ, Joseph V, Kannappan V, Roopsingh D. A simple approach to the synthesis of hexagonal-shaped silver nanoplates. J Nanomater. 2011;2011:825637.
46. Gao XH, Wei LQ, Wang J, Xu BS. Green synthesis of starch-stabilized silver nanoparticles and their antibacterial properties. Adv Mater Res. 2011;236-238:1945-1948.
47. Lee GP, Bignell LJ, Romeo TC, et al. The citrate-mediated shape evolution of transforming photomorphic silver nanoparticles. Chem Commun. 2010;46(41):7807-7809.
48. Jiang XC, Chen WM, Chen CY, Xiong SX, Yu AB. Role of temperature in the growth of silver nanoparticles through a synergetic reduction approach. Nanoscale Res Lett. 2011;6(1):32.
49. Zabetakis K, Ghann WE, Kumar S, Daniel M. Effect of high gold salt concentrations on the size and polydispersity of gold nanoparticles prepared by an extended Turkevich-Frens method. Gold Bull. 2012;45(4):203-211.
50. Chandran SP, Chaudhary M, Pasricha R, Ahmad A, Sastry M. Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotechnol Prog. 2006;22(2):577-583.
51. Mitra B, Vishnudas D, Sant SB, Annamalai A. Green-synthesis and characterization of silver nanoparticles by aqueous leaf extracts of Cardiospermum helicacabum leaves. Drug Invent Today. 2012;4(2):340-344.
52. Cytodiagnostics [website on the Internet]. Burlington, ON, Canada: Cytodiagnostics. Available from: http://www.cytodiagnostics.com. Accessed March 2, 2013.
53. Shankar SS, Bhargava S, Sastry M. Synthesis of gold nanospheres and nanotriangles by the Turkevich approach. J Nanosci Nanotechnol. 2005;5(10):1721-1725.
54. Mukherjee P, Nandi AK. Bimetallic Au(core)-Ag(shell) nanoparticles from interfacial redox process using poly(o-methoxyaniline). J Colloid Interface Sci. 2010;344(1):30-36.
55. Klein J. Probing the interactions of proteins and nanoparticles. Proc Natl Acad Sci U S A. 2007;104(7):2029-2030.
56. Costertan JW, Montataro L, Arciola R. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005;28(11):1062-1068.
57. Pour NK, Dusane DH, Dhakephalkar PK, Zamin FR, Zinjarde SS, Chopade BA. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol Med Microbiol. 2011;62(3):328-338.
58. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322-332.
59. National Institutes of Health. Targeted research on oral microbial biofilms. 1998. Available from: http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-98-006.html. Accessed April 3, 2013.
60. Rodrigues L, van der Mei HC, Teixeira JA, Oliveira R. Biosurfactant from Lactococcus lactis 53 inhibits microbial adhesion on silicone rubber. Appl Microbiol Biotechnol. 2004;66(3):306-311.
61. Augustine N, Ali-Vehmas T, Atroshi F. Assesment of enzymatic cleaning agents and disinfectants against bacterial biofilms. J Pharm Pharm Sci. 2004;7(1):55-64.
62. Thawal ND, Yele AB, Sahu PK, Chopade BA. Effect of a novel podophage AB7-IBB2 Poster presented at: Second International Translational Nanomedicine Conference; July 26-28, 2013; Boston, MA.
63. Chopade BA, Ghosh S, Jagtap S, et al. Dioscorea bulbifera mediated synthesis of AgNPs exhibiting novel antibiofilm and antileishmanial activity. In: International Translational Nanomedicine: ITNANO; July 26-28, 2013; Northeastern University, Boston, USA. Abstract 59.
64. Shrestha A, Shi Z, Neoh KG, Kishen A. Nanoparticulates for antibiofilm treatment and effect of aging on its antibacterial activity. Basic Res Technol. 2010;36(6):1030-1035.
65. Kalishwaralal K, BaraManiKanth S, Pandian SR, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces. 2010;79(2):340-344.
66. Chopade BA, Patwardhan RB, Dakephalkar PK. Acinetobacter infections in India: genetic and molecular biology studies and some approaches to the problem. In: Sushil Kumar, Sen AK, editors. Tropical Diseases: Molecular Biology and Control strategies. New Delhi: Council of Scientific and Industrial Research; 1994:704-716.
67. Patil JR, Jog NR, Chopade BA. Isolation and characterization of Acinetobacter from upper respiratory tract of healthy humans and demonstration of lectin activity. Indian J Med Microbiol. 2001;19(1):30-35.
68. Pardesi KR, Yavankar SP, Chopade BA. Plasmid distribution and antimicrobial susceptibility patterns of Acinetobacter genospecies from healthy skin of a tribal population in western India. Indian J Med Res. 2007;125(1):79-88.
69. Patil JR, Copade BA. Studies on bioemulsifier production by Acinetobacter strains isolated from healthy human skin. J Appl Microbiol. 2000;91(2):290-298.
70. Robenshtok E, Paul M, Leibovici L, et al. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect. 2006;64(3):282-287.
71. Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis. 2007;13(1):97-103.
72. Dent LL, Marshall DR, Pratap S, Hulette RB. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis. 2010;10(196).
73. Oh YJ, Jo W, Yang Y, Park S. Influence of culture conditions on Escherichia coli O157: H7 biofilm formation by atomic force microscopy. Ultramicroscopy. 2007;107(10-11):869-874.
74. Dufrene YF. Using nanotechniques to explore microbial techniques. Nat Rev Microbiol. 2004;2(6):451-460.